NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY.
Normax Blog2022-11-13T17:18:00+00:00

Normax Post

FOR KNOWLEDGE SHARING AND EDUCATIONAL PURPOSES ONLY.

NEWS. Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine – 04 NOV 2022

4 NOV Pfizer PR 18 NOV Pfizer PR Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years of age One-month after a 30-µg booster dose of the bivalent vaccine, [...]

VIEWPOINT. Dangerous, Continuous, Uncontrollable Global Evolution of Multiple SARS-CoV-2 “Variants of Concern” Toward Immune Escape with Unpredictable Long-term Consequences…

5 minutes (overview). Why are more infections of SARS-CoV-2 variants of concern dangerous? SARS-CoV-2 variants can become less deadly, or more deadly, over time. Viral evolution occurs entirely by random chance. SARS-CoV-2 variants immune escape is clearly occuring now, under pressure from natural and vaccine induced [...]

REVIEW. NATURE Biotechnology. Unlocking the promise of mRNA therapeutics – 03 NOV 2022

Review Article Published: 03 November 2022 Unlocking the promise of mRNA therapeutics Eduarde Rohner, Ran Yang, Kylie S. Foo, Alexander Goedel & Kenneth R. Chien Nature Biotechnology (2022) Abstract The extraordinary success of mRNA vaccines against coronavirus disease 2019 (COVID-19) has renewed interest in mRNA as a means of delivering therapeutic proteins. Early [...]

NEWS. Pfizer COVID Vaccine Price Hike: $110 to $130 per dose – 20 OCT 2022

Pfizer eyes four-fold price hike for COVID vaccine in private US market – 21 OCT 2022 – FiercePharma. Pfizer revealed during an investor call that it is considering charging a private-market price between $110 and $130 per dose for its COVID shot Comirnaty, which was co-developed by BioNTech. The price [...]

REPORTS. Long-Term Market Outlook for mRNA Vaccines and Therapeutics and SARS-CoV-2 Vaccines for Endemic COVID-19

Long-term Market Outlook Reports... Global mRNA Vaccines Market to Reach $127.3 Billion by 2027. REPORT The global market for mRNA Vaccines estimated at US$64.9 Billion in the year 2021, is projected to reach a revised size of US$127.3 Billion by 2027, growing at a CAGR of 11.9% over the [...]

NEWS. SPIEGEL INTERNATIONAL. Epidemiologist Jeremy Farrar on the Next Viral Threat “I Fear We Are at the Beginning of an Era of Pandemics”.

Epidemiologist Jeremy Farrar on the Next Viral Threat “I Fear We Are at the Beginning of an Era of Pandemics” In an interview, infectious diseases expert Sir Jeremy Farrar discusses recent mutations of the coronavirus and his worries about future pandemics. He says COVID is here to stay and [...]

EVENT. Normax at Raising Capital Summit 2022, Dublin, Ireland, NOV 16

Peter A. Jensen, CEO & Chairman, Normax Biomed, will be speaking at The Raising Capital Summit 2022 in Dublin, Ireland, on “raising equity capital from international investors”. Mr. Jensen's session will explain how Normax Biomed is "Bridging 'The Valley of Death' with a faster and safer crossing by Securing [...]

EVENT. Normax at Jefferies London Healthcare Conference, NOV 15 and 17

Peter A. Jensen, CEO & Chairman, to Showcase Normax, 1x1, at Jefferies London Healthcare Conference, NOV 15 and 17 Jefferies Investor Conferences As an active and engaged participant in the financial community and the industries we serve, Jefferies hosts various investor conferences and summits throughout the year. The Jefferies [...]

EVENT. Normax at LSX Investival Showcase, London, NOV 14

Peter A. Jensen, CEO & Chairman, to Showcase Normax at LSX Investival Showcase, London, NOV 14 Connecting life science and healthcare corporates with capital and deal-makers as part of Europe’s biggest healthcare investment week. Returning for its seventh year and back in person, Inv€$tival Showcase offers up 5 incredible [...]

NEWS. NATURE Biotechnology. mRNA printers kick-start personalized medicines for all – 09 August 2022

News Published: 09 August 2022 mRNA printers kick-start personalized medicines for all Cormac Sheridan Nature Biotechnology volume 40, pages 1160–1162 (2022)Cite this article mRNA printers will bring low-cost vaccines and made-to-order treatments for a range of different diseases. South Africa is setting up mRNA manufacture with new technologies that will ensure [...]

WEBINAR. Merck. Key Considerations for the Development of Lipid Nanoparticles for RNA Delivery

1 minute (overview). Key Considerations for the Development of Lipid Nanoparticles for RNA Delivery WEBINAR The success of mRNA-based vaccines for COVID-19 lays the path to accelerate the development of this modality for many other diseases. Key decisions must be made early in the drug development process [...]

VIEWPOINT. Leading mRNA Biomedical and mRNA Biotech Companies

1 minute (overview). Industry Reference Data (Public Info) TICKER    MARKET CAP    LINK MRNA     $48 Billion       Moderna, Inc.  BNTX      $32 Billion        BioNTech SE ALNY      $24 Billion        Alnylam Pharmaceuticals, Inc. SRPT      $9.8 Billion        Sarepta Therapeutics, Inc.  IONS      $6.4 Billion        [...]

FACT. Vaccines Save Lives. REPORT. THE LANCET. For the first year of vaccines, over 20 million lives are estimated to have been saved around the world December 2020-21.

1 minute (overview). ESG Social Impact Data; COVID-19 Vaccines For the first year of vaccines, over 20 million lives are estimated to have been saved around the world December 2020-21. The Lancet  The quality-adjusted life year (QALY) is a generic measure of disease burden, including both the [...]

EDITORIAL. Time for mRNA vaccine equality across the globe to save more lives. by Peter A. Jensen, CEO & Chairman, Normax

EDITORIAL. European Pharmaceutical Manufacturer - 8 September 2022 Peter Jensen, CEO and Chairman, Normax delves into why it’s time for mRNA vaccine equality to be established across the globe. He also goes on to explain how mRNA vaccines can help drive down the costs of vaccines, save more lives [...]

WHO REPORT. Every 20 seconds someone died of Tuberculosis in 2021.

Tuberculosis (TB) truly is the scourge of humanity. Since the dawn of time, about 106 billion people have lived on earth and about 1% have died of TB. Over 1 billion people have died of TB. Tuberculosis deaths and disease increase during the COVID-19 pandemic. 27 October 2022 News [...]

VIEWPOINT. Disinformation is Dangergous for Global Public Health, Pandemic Preparedness, and Personal Health

Disinformation can be deadly. Links for educational purposes: The Vaccine Confidence Project Ground Truths - Dr. Eric Topol A gateway conspiracy? Belief in COVID-19 conspiracy theories prospectively predicts greater conspiracist ideation - PLOS ONE Science, misinformation, and the role of education - Science Knowledge overconfidence is associated with anti-consensus [...]

VIEWPOINT. SCIENCE TRANSLATIONAL MEDICINE. Vaccines 2020: The era of the digital vaccine is here – 15 Dec 2021

Vaccines 2020: The era of the digital vaccine is here MARIAGRAZIA PIZZA, SIMONE PECETTA and RINO RAPPUOLI SCIENCE TRANSLATIONAL MEDICINE 15 Dec 2021 Vol 13, Issue 624 DOI: 10.1126/scitranslmed.abm3249 Reproduced for educational purposes. ABSTRACT The SARS-CoV-2 pandemic has generated a renaissance in vaccinology, with COVID-19 mRNA vaccines delivering a “digital code” [...]

NIH REPORT. National Human Genome Research Institute. Cost per Raw Megabase of DNA Sequence.

Wetterstrand KA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP) DNA Sequencing Costs: Data For many years, the National Human Genome Research Institute (NHGRI) has tracked the costs associated with DNA sequencing performed at the sequencing centers funded by the Institute. This information has served as an [...]

ABOUT PRIMARY DIRECT LISTING. Nasdaq Direct Listings offer a different way to go public with unrestricted liquidity and no lock-up period.

What is a direct listing at Nasdaq? A direct listing allows companies to list on Nasdaq without concurrently raising capital. Typically, a company will list securities on a national securities exchange to provide restricted liquidity to existing shareholders and to raise capital via an Initial Public Offering (IPO). A direct [...]

MISSION BY NORMAX. NO PANDEMICS. Pathogens and Outbreaks are inevitable. Pandemics are not.

Our Mission Our mission is to participate as a strategic partner in the global ecosystem for transformative research, development and manufacture of safe and effective mRNA vaccines for global public health and pandemic preparedness and prevention, with competitive financial performance. Learn More

Go to Top